Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT02962570
Other study ID # IRB_00094640
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date November 2016
Est. completion date November 1, 2024

Study information

Verified date November 2023
Source University of Utah
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The main goal of this study is to determine if supplemental oxygen given only when the patient is inspiring (demand delivery) is more effective than constant-flow oxygen given during all phases of the breath regardless if the patient is breathing it in. A previous study in volunteers (NCT02886312) showed that the oxygen saturation in the blood and the concentration of oxygen breathed out from the lungs (end-tidal oxygen) was higher when given in demand (inhalation only) mode. A secondary goal is to determine in patients, whether turning oxygen delivery off during expiration improves the accuracy of end-tidal CO2 (Carbon Dioxide) monitoring. This was found to be the case in the previous volunteer study. The investigators want to determine if these improvements are also observable in relatively healthy patients undergoing procedural sedation and analgesia. The efficacy of the demand mode will be determined by measuring the resulting difference in oxygen saturation and end-tidal oxygen levels. The investigators will alternate between traditional oxygen delivery (continuous flow) and demand delivery (flow only during inhalation) for two minutes in each mode after which oxygen saturation and end-tidal oxygen will be measured. End-tidal CO2 measurement will be compared with those during the brief time when O2 flow is stopped.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 100
Est. completion date November 1, 2024
Est. primary completion date November 1, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - ASA class I-III Exclusion Criteria: - Procedures scheduled for a lime less than 20 minutes - Age < 18 years - Baseline SpO2 (arterial oxygen saturation as measured by pulse oximetry) < 93% on room air - ARDS (Acute respiratory distress syndrome), lung disease, cardiovascular disease - ASA class IV or above - Pregnant women.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
On Demand Oxygen Delivery
Supplemental oxygen flow is controlled such that it is on only during inhalation.
Traditional, Always-On, Oxygen Delivery
Supplemental oxygen flow is constantly on, irrespective of whether the patient is inhaling or exhaling.
Oxygen Flow Stopped
Supplemental oxygen flow is stopped completely for a brief period to allow undisturbed end-tidal oxygen and CO2 measurements

Locations

Country Name City State
United States University of Utah Salt Lake City Utah

Sponsors (1)

Lead Sponsor Collaborator
University of Utah

Country where clinical trial is conducted

United States, 

References & Publications (3)

Bliss PL, McCoy RW, Adams AB. Characteristics of demand oxygen delivery systems: maximum output and setting recommendations. Respir Care. 2004 Feb;49(2):160-5. — View Citation

Fuhrman C, Chouaid C, Herigault R, Housset B, Adnot S. Comparison of four demand oxygen delivery systems at rest and during exercise for chronic obstructive pulmonary disease. Respir Med. 2004 Oct;98(10):938-44. doi: 10.1016/j.rmed.2004.03.010. — View Citation

Godbold S, Lowe G, Willis R. Healthcare Professionals Accuracy and Consistency in Setting Oxygen Flowmeters for Patients in an Intensive Care Unit. Respir. Care 59(10):OF26, December 2014.

Outcome

Type Measure Description Time frame Safety issue
Primary End-tidal Oxygen Did the novel system increase end-tidal oxygen? measured every 140 seconds minutes throughout the surgical procedure
Primary Oxygen Saturation Did the novel system increase oxygen saturation? measured continuously with every heart beat (i.e., approx. every 500-2000msec) throughout the surgical procedure
Primary End-tidal Carbon Dioxide Was end-tidal carbon dioxide measured more accurately using the novel system? measured every 140 seconds minutes throughout the surgical procedure
See also
  Status Clinical Trial Phase
Not yet recruiting NCT04959136 - Feasibility Study Of Ambulatory Monitoring System N/A
Recruiting NCT04481308 - Non-invasive Carbon Dioxide Monitoring and Endoscopic Retrograde Cholangiopancreatography Patients
Completed NCT03574272 - Patient Transfer Monitoring System in Hospital Using Mobile IoT Technology N/A
Not yet recruiting NCT03764709 - Continuous Wireless Monitoring in Internal Medicine Unit: the Green Line From Hospital to Territory N/A
Completed NCT04472208 - AMS Evaluation Study N/A
Completed NCT02886312 - Evaluation of Oxygen Delivery Through Nasal Cannula in Volunteers N/A
Terminated NCT03039738 - Surveillance Monitoring as an Alternative to Telemetry N/A
Completed NCT02571465 - Assessment of Fluid Responsiveness in Patients After Cardiac Surgery N/A